Mitochondria‐Targeted Nanosystem with Reactive Oxygen Species‐Controlled Release of CO to Enhance Photodynamic Therapy of PCN‐224 by Sensitizing Ferroptosis

Abstract

AbstractThe apoptosis‐resistant mechanism of photodynamic therapy (PDT) usually results in limited therapeutic efficacy. The development of new strategies for sensitizing targeted ferroptosis that bypass apoptosis resistance is of great significance to improve the antitumor efficacy of PDT. In this study, a novel amphiphilic copolymer whose main chain contains reactive oxygen species (ROS)‐responsive groups and the end of side chains contains triphenylphosphine is synthesized, to encapsulate porphyrinic metal–organic framework PCN‐224 via self‐assembly which are hydrothermally synthesized by coordination of zirconium (IV) with tetra‐kis(4‐caboxyphenyl) porphyrin, and loaded carbon monoxide releasing molecule 401 (CORM‐401) by their hollow structures (PCN‐CORM), and finally, surface‐coated with hyaluronic acid. The nanosystem can sequentially localize to mitochondria which is an important target to induce apoptosis and ferroptosis in cancer cells. Upon excitation with near‐infrared light, PCN‐224 is activated to produce amounts of ROS, and simultaneously triggers the rapid intracellular release of CO. More importantly, the released CO can sensitize ferroptosis and promote apoptosis to significantly enhance the antitumor efficacy of PCN‐224 both in vitro and in vivo. These results illustrate that the mitochondria‐targeted drug delivery system combined PDT with CO leads to an effective antitumor efficacy, which maybe a promising way to enhance the treatment efficiency of PDT.